Rakuten, Progressive and Alphabet-backed online lending platform Upstart has closed its initial public offering, its share price having more than doubled since it floated.

Shea Ventures is in line for an exit after the fashion e-commerce marketplace filed to raise up to $100m in its initial public offering.

The Bertelsmann and CAA-backed dog product supplier will secure a New York Stock Exchange listing and $200m in PIPE financing.

The Saudi Aramco and Schlumberger-backed chemical analysis device makers shares have nearly tripled in price since it went public on Friday.

The Alphabet and Tencent-backed robotic process automation technology provider was valued at $10.2bn in its last funding round.

BBVA, New York Stock Exchange, NTT Docomo and USAA could be in line to exit the crypto trading platform developer, which was valued at $8bn two years ago.

The UBC-linked antibody drug developer has added $73m to its initial public offering, and its shares are still trading at more than double the IPO price.

The Eli Lilly-backed antibody drug developer has added $73m to its initial public offering, and its shares are still trading at more than double the IPO price.

Rakuten, Progressive and GV-backed online lending platform developer floated at the bottom of its range before a first-day pop.

Pfizer Ventures-backed cancer drug developer BioAtla's shares popped on its first day of trading yesterday following a $189m initial public offering.